<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03147261</url>
  </required_header>
  <id_info>
    <org_study_id>UNavarre</org_study_id>
    <nct_id>NCT03147261</nct_id>
  </id_info>
  <brief_title>Impact of Comprehensive Intervention on the Cardiometabolic Risk in Children With Central Obesity (IGENOI)Obesity</brief_title>
  <acronym>IGENOI</acronym>
  <official_title>Impacto de Una intervención Integral Sobre el Riesgo cardiometabólico en niños Con Obesidad Central: Estudio de Marcadores genéticos y epigenéticos</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinica Universidad de Navarra, Universidad de Navarra</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Navarra</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinica Universidad de Navarra, Universidad de Navarra</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Central obesity, present in the metabolic syndrome (MS), is associated with increased risk of
      insulin resistance (RI). The aim of the project is to evaluate the protective effect of
      comprehensive intervention (Mediterranean diet + physical activity) in the development of RI
      in children with central obesity based on genetic and epigenetic markers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives: 1) Apply a comprehensive therapeutic nutrition intervention program for
      monitoring the Mediterranean Diet (DM) slightly hypocaloric along with increased physical
      activity in children with central obesity 7-16 years). 2) Measure the effectiveness of this
      program by assessing changes in body composition, lifestyle and biological and molecular
      parameters (genetic and epigenetic).

      Methodology: test randomized, longitudinal, controlled, two-year intervention field comparing
      a sample of 120 subjects from 7 to 16 years with central obesity, the effect of two
      interventions: a) intensive on lifestyle with a reduced calorie DM , physical activity and
      behavioral therapy, b) non-intensive with healthy diet recommendations following the usual
      pediatric advice. At 2, 6, 12 and 24 months after follow up changes will be assessed: a) the
      HOMA index, body fat, and the cardiovascular risk factors, b) diet, sleep patterns, physical
      exercise using questionnaires and accelerometers (intervention group), and c) the quality of
      life. genetic and epigenetic markers will be evaluated by genotyping SNPs genes related to
      RI; and the analysis of: a) DNA methylation in genes related to insulin resistance, b)
      expression of microRNAs and target genes related to insulin resistance and c) measure the
      length of telomeres. The therapeutic program will consist of individual sessions and group
      workshops for the patient and the family.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes in the HOMA index</measure>
    <time_frame>At 2, 6, 12 and 24 months after follow up</time_frame>
    <description>changes will be assessed in the HOMA index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>genetic and epigenetic markers will be evaluated</measure>
    <time_frame>At 2, 6, 12 and 24 months after follow up</time_frame>
    <description>genetic and epigenetic markers will be evaluated by genotyping SNPs genes related to RI; and the analysis of: a) DNA methylation in genes related to insulin resistance, b) expression of microRNAs and target genes related to insulin resistance and c) measure the length of telomeres</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pediatric Obesity</condition>
  <arm_group>
    <arm_group_label>lifestyle intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intensive follow up in lifestyle factors with a reduced calorie DM , physical activity and behavioural therapy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Healthy diet recommendations following the usual pediatric advice</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lifestyle intervention</intervention_name>
    <description>Intensive changes in lifestyle with a reduced calorie mediterranean diet, physical activity and behavioral therapy</description>
    <arm_group_label>lifestyle intervention</arm_group_label>
    <other_name>No intervention</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Signed informed consent by the child, parent or guardian. 3. waist circumference above
        the 90th percentile 4. Motivation and willingness to be assigned to either group, and do
        their utmost to follow protocol assigned.

        5. Possibility of involvement in days of intensive phase (week 0, 1, 2, 3, 4, 5, 6, 7 and
        8) and once a month until 6 months later at 4 months and every 6 months during the second
        year.

        Exclusion Criteria:

          1. Pre-Diabetes

          2. Presence of other diseases

          3. Pharmacotherapy

          4. Monitoring special diets

          5. Food intolerance

          6. Regular alcohol consumption

          7. Drug

          8. Psychiatric illness or eating disorder

          9. People without telephone or Internet access
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amelia Marti, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Navarra</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cristina Azcona, MD</last_name>
    <phone>948255400</phone>
    <email>cazcona@unav.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cristina Azcona, MD</last_name>
    <email>cazcona@unav.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UNavarre</name>
      <address>
        <city>Pamplona</city>
        <state>Navarra</state>
        <zip>31008</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amelia Marti, PhD</last_name>
      <phone>34948425600</phone>
      <phone_ext>806244</phone_ext>
      <email>amarti@unav.es</email>
    </contact>
    <contact_backup>
      <last_name>Cristina Azcona SanJulian, PhD, MD</last_name>
      <email>cazcona@unav.es</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2017</study_first_submitted>
  <study_first_submitted_qc>May 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 10, 2017</study_first_posted>
  <last_update_submitted>May 5, 2017</last_update_submitted>
  <last_update_submitted_qc>May 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

